Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marillion acquires rights to xerostomia treatment
CPSI’s Pilobuc insert is based on a hydrogel polymer technology that delivers drugs to the buccal mucosa. Pilobuc allows for the sustained buccal delivery of pilocarpine while reducing
CPSI’s Pilobuc insert is based on a hydrogel polymer technology that delivers drugs to the buccal mucosa. Pilobuc allows for the sustained buccal delivery of pilocarpine while reducing
One of these agreements is for the conjoint clinical development of aerosolized AAT for treating the indications of cystic fibrosis and bronchiectasis, in addition to Alpha-1 Antitrypsin Deficiency
agClinical, designed for the smaller life sciences companies, provides core trial management functionality and offers easy integration with multiple clinical applications, while agClinical NW helps large companies perform
Upon Mr. Moran’s retirement, Gary Siegel, currently vice president of finance, will assume the roles of principal accounting officer and principal financial officer. Mr. Siegel has served the
Omnitrope, a follow-on biologic, is approved for the long-term treatment of pediatric patients who have growth failure and long-term replacement therapy in adults with growth hormone deficiency. The
The product, developed by Debiopharm for the treatment of acute esophageal variceal bleeding (EVB), is currently under review for approval by the Canadian Health Authorities. In addition to
Now this agreement extended for four more years until March 2012, Astellas will continue to have access to MorphoSys’s proprietary antibody library HuCAL Gold at its research site
Separately, Essilor International’s subsidiary Essilor Canada has acquired a majority stake in Westlab Optical, a prescription laboratory located in Montreal. The partnership focuses primarily on developing the company’s
Bayer HealthCare will use Millipore’s UCOE (Ubiquitous Chromatin Opening Element) technology to manufacture biologic drugs. The license will enable Bayer to more efficiently manufacture recombinant proteins in mammalian
Zentase is a porcine-derived pancreatic enzyme replacement therapy which is being developed to treat pancreatic insufficiency. Gearoid Faherty, CEO of Eurand, said: “We understand that the typical FDA